SubscribeLogin
Published

CYB003's Remission Rates And Gaetz's Appointment Looms

Summary by The Dales Report
On our latest Trade To Black Podcast, we’re going to take a look at Cybin’s psychedelic breakthroughs with CYB003 with CEO Doug Drysdale, Eaze Technologies’ cannabis expansion plans, and the latest political developments in Washington, DC which might impact the industry. Cybin’s (NYSE:CYBN) CEO Doug Drysdale explains their latest trials, where they reported a groundbreaking 71% remission rate in patients with major depressive disorder (MDD) usin…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Washington DCWashington DC
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal